The cardiac safety of trastuzumab in the treatment of breast cancer

ISSN： 1474-0338

Source： Expert Opinion on Drug Safety, Vol.9, Iss.2, 2010-03, pp. : 335-346

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Docetaxel/trastuzumab combination therapy for the treatment of breast cancer

By Nabholtz Jean-marc Gligorov Joseph

Expert Opinion on Pharmacotherapy, Vol. 6, Iss. 9, 2005-08 ,pp. : 1555-1564

Informa Healthcare

Access to resources Recommend Favorite

Cost Effectiveness of Trastuzumab in the Adjuvant Treatment of Early Breast Cancer: A Lifetime Model

By Millar J. Alasdair Millward Michael J.

PharmacoEconomics, Vol. 25, Iss. 5, 2007-01 ,pp. : 429-442

Adis International

Access to resources Recommend Favorite

Trastuzumab in Early-Stage Breast Cancer: The Question of Treatment Timing

By Simoens Steven

PharmacoEconomics, Vol. 26, Iss. 10, 2008-01 ,pp. : 807-809

Adis International

Access to resources Recommend Favorite

Neoadjuvant trastuzumab promising in breast cancer

Inpharma, Vol. 1, Iss. 1484, 2005-01 ,pp. : 18-18

Adis International

Access to resources Recommend Favorite

In defence of trastuzumab for early breast cancer

Inpharma, Vol. 1, Iss. 1521, 2006-01 ,pp. : 3-3

Adis International

Access to resources Recommend Favorite